Early Lymphocyte Collection for Anti-CD19 CART Production Improves T-Cell Fitness in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Scientists conducted a prospective study and evaluated the potential benefit of an earlier lymphopheresis on the clinical outcome of CD19-CART infused DLBCL patients, in comparison with standard lymphopoiesis.